CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced that its Chief Executive Officer, Dr. Phillip Chan, and Chief Financial Officer, Mr. Peter Mariani, will attend and participate in one-on-one meetings with investors at the Jefferies Global Healthcare Conference […]

Calling all my single travelers! EF Go Ahead Tours Launches New Solo Tours and Tours for Women that include Champagne Tastings in France at Veuve Clicquot, visits with Pearl Divers in Japan, and Kiwi Culture in New Zealand

EF World Journeys celebrates “Singles Day” also with discounted tours for women at EF Ultimate Break and stackable deals for solo travelers at EF Adventures EF Go Ahead Tours, the tour operator for all ages, families and customized group tours just asked, “Where all my single travelers at?” https://mma.prnewswire.com/media/2537279/EF_Go_Ahead_Tours_Logo.jpg This Singles Day, November 11, EF

RoadMap Technologies Releases RoadMap Data Aggregation Service 2.0

RoadMap's Data Aggregation Service (DAS) allows healthcare organizations to deidentify Electronic Medical Records and other unstructured data. RoadMap Technologies, a leading provider of data science and software solutions today announced the release of RoadMap DAS 2.0. DAS 2.0's updated service offerings focus on giving researchers the ability to analyze Electronic Medical Records while maintaining privacy

BitMart Global CEO to Speak at HKU: A New Generation Steps Into Web3

Hong Kong, Nov. 11, 2025 (GLOBE NEWSWIRE) — On November 21, BitMart, a leading global cryptocurrency exchange, will join forces with 0xU Hong Kong Blockchain Club to host “Entering the Web3 Workplace“ at The University of Hong Kong (HKU) — a fireside event spotlighting how blockchain, AI, and digital finance are re-wiring the global economy

Ceragon Reports 2025 Third Quarter Financial Results

Company delivers solid revenue, margin, and cash flow in third quarter, with improved visibility Ceragon (NASDAQ: CRNT), a leading solutions provider of end-to-end wireless connectivity, today reported its financial results for the third quarter period ended September 30, 2025. https://mma.prnewswire.com/media/1704355/Ceragon_Networks_Ltd_Logo.jpg Q3 2025 Financial Highlights: — Revenues of $85.5 million — Operating income of $3.8 million

Mutuum Finance (MUTM) Approaches $20M Raised as Community Surpasses 17,900 Holders Toward V1 launch

DUBAI, United Arab Emirates, Nov. 11, 2025 (GLOBE NEWSWIRE) — Momentum around Mutuum Finance (MUTM) has continued to build throughout 2025 as the project moves steadily toward its first public testnet release. Growth across the presale, community expansion and confirmed development milestones are now converging, creating a noticeable surge of activity within the project's ecosystem.

AlorAir Dehumidifiers Certified Under the Latest ENERGY STAR(R) Efficiency Standards for Superior Energy Savings

Chino, California, Nov. 11, 2025 (GLOBE NEWSWIRE) — AlorAir, a leading innovator in dehumidification technology, announced that its flagship portable dehumidifiers have officially received 2025 ENERGY STAR(R) certification. This confirms that AlorAir's products meet the latest U.S. Department of energy efficiency standards, effective October 2025. The updated specification raises the bar, so dehumidifiers deliver the

Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value

(NasdaqGM:NEUP), Confirms Receipt of Unsolicited Indication of Interest and Director Nominations from Lynx1 Master Fund LP No Stockholder Action Required at This Time BURLINGTON, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) — Neuphoria Therapeutics Inc. (“Neuphoria” or the “Company”) (Nasdaq: NEUP), a clinical-stage biotechnology company developing impactful treatments for neuropsychiatric disorders, today announced, as previously disclosed,

Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement

(NASDAQ:SLNO), REDWOOD CITY, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today that its Board of Directors has authorized a share repurchase and that it has entered into an Accelerated Share Repurchase Agreement (“ASR”) with Jefferies LLC

Aya Gold & Silver Reports Record Revenue and Net Income for Q3-2025 on Record Production

(TSX:AYA),(OTC US:AYASF),(Other OTC:AYASF), MONTREAL, Nov. 11, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) today announced third quarter financial and operational results for the three-month period ended September 30, 2025. All amounts are in US dollars, unless otherwise stated. Q3-2025 Highlights Operational Record silver production of

Scroll to Top